Early versus delayed autologous stem cell transplantation in patients receiving novel therapies for Multiple Myeloma

Autologous stem cell transplant (ASCT) is an effective treatment for multiple myeloma (MM). However the timing of ASCT in the era of novel agents (lenalidomide, thalidomide, bortezomib) is unknown. We retrospectively reviewed the outcome of MM patients who received novel agent based induction treatm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dunavin, Neil C., Wei, Lai, Elder, Patrick, Phillips, Gary S, Benson, Don M, Hofmeister, Craig C., Penza, Sam, Greenfield, Carli, Rose, Karen S., Rieser, Gisele, Merritt, Lisa, Ketcham, Jill, Heerema, Nyla, Byrd, John C., Devine, Steven M., Efebera, Yvonne A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769940/
https://ncbi.nlm.nih.gov/pubmed/23194056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2012.751528
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados